April 16, 2025
Trending News

In the United States announced a new threat from the “zombie drug”

  • April 12, 2023
  • 0

He US government this environment was officially described as an “emerging threat” in the country. fentanyl adulterated or mixed with xylazinea strong animal sedative used as a drug.

In the United States announced a new threat from the “zombie drug”

He US government this environment was officially described as an “emerging threat” in the country. fentanyl adulterated or mixed with xylazinea strong animal sedative used as a drug.

The White House said in a statement that the new designation came after evaluating xylazine’s impact on the opioid crisis and its growing role in Overdose deaths “in all regions of the United States”.

White House Drug Policy Director Rahul Gupta indicated that with this designation Joe Biden administration is “active” in its quest to save lives and create new tools for public health and safety.

His cabinet, the White House Office of National Drug Control Policy (ONDCP), has among its tasks monitoring new trends in drug use and establishing criteria to classify it as an emerging threat.

The fentanyl-xylazine mixture falls into this category because it is sold “illicitly” and is associated with “significant and rapidly deteriorating adverse health effects”, including “fatal overdoses and severe illness”.

The White House recalls that, according to the US Drug Enforcement Administration (DEA), xylazine overdose deaths increased by 1127% in the South of the country between 2020 and 2021, 750% in the West, over 500% in the Midwest, and over 100% in the Northeast.

“Despite the fact that the number of overdose deaths in the country has stabilized or decreased for seven consecutive months, xylazine complicates efforts to reverse opioid overdoses‘ said the President of the United States.

With the announcement of this drug as a new threat, the Biden administration is pursuing a strategy that includes prevention based on existing evidence. treatment and supply reduction.

As early as March last year, US authorities imposed a partial import ban on xylazine.

Since then, the drug has been subject to increased scrutiny by the Food and Drug Administration (FDA), whose officials will be able to stop the shipment of the product if its legitimate veterinary use is not properly verified.

This Wednesday’s announcement comes a day after the United States said it would be stepping up its strategy against consumption and trafficking of fentanyl from Mexico, following weeks of criticism and cross-talk with a neighboring country to crack down on the synthetic drug.

A delegation from the Mexican government led by Secretary for Security and Citizens Protection Rosa Isela Rodriguez is heading to Washington today to meet with US and Canadian executive officials. meeting on fentanyl trafficking and on other issues such as migration or weapons.

EFE

Source: Aristegui Noticias

Leave a Reply

Your email address will not be published. Required fields are marked *